Home NDC 68229-200 Alocane
Product NDC 68229-200
11-digit product format 682290200
Labeler code 68229
Product ID 68229-200_cdb574f7-23b3-4f99-8b63-a92f5625a76a
Type HUMAN OTC DRUG
Nonproprietary name Lidocaine Hydrochloride
Dosage form OINTMENT
Route TOPICAL
Labeler Quest Products, Inc.
Application part348
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2013-06-01
Marketing end 0000-00-00
Substance LIDOCAINE HYDROCHLORIDE
Active strength 4 g/100mL
NDC exclude flag No
Listing certified through 2019-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 30 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 68229-200-02 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 68229-200-02 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 68229-200-02 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 68229-200-02 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 68229-200-02 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 68229-200-02 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 68229-200-02 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 68229-200-02 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 68229-200-02 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 68229-200-02 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 68229-200-02 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 68229-200-02 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 68229-200-02 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 68229-200-02 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 68229-200-02 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Lidocaine Hydrochloride ACTIVE INGREDIENT V13007Z41A ALOCANE (LIDOCAINE HYDROCHLORIDE) OINTMENT [QUEST PRODUCTS, INC.] 1 Lidocaine ACTIVE MOIETY 98PI200987 ALOCANE (LIDOCAINE HYDROCHLORIDE) OINTMENT [QUEST PRODUCTS, INC.] 1 .Alpha.-Tocopherol Acetate INACTIVE INGREDIENT 9E8X80D2L0 ALOCANE (LIDOCAINE HYDROCHLORIDE) OINTMENT [QUEST PRODUCTS, INC.] 1 Aloe Vera Leaf INACTIVE INGREDIENT ZY81Z83H0X ALOCANE (LIDOCAINE HYDROCHLORIDE) OINTMENT [QUEST PRODUCTS, INC.] 1 Caprylyl Glycol INACTIVE INGREDIENT 00YIU5438U ALOCANE (LIDOCAINE HYDROCHLORIDE) OINTMENT [QUEST PRODUCTS, INC.] 1 Chlorphenesin INACTIVE INGREDIENT I670DAL4SZ ALOCANE (LIDOCAINE HYDROCHLORIDE) OINTMENT [QUEST PRODUCTS, INC.] 1 Dimethyl Isosorbide INACTIVE INGREDIENT SA6A6V432S ALOCANE (LIDOCAINE HYDROCHLORIDE) OINTMENT [QUEST PRODUCTS, INC.] 1 Hydroxyethyl Cellulose (5500 MPA.S at 2%) INACTIVE INGREDIENT M825OX60H9 ALOCANE (LIDOCAINE HYDROCHLORIDE) OINTMENT [QUEST PRODUCTS, INC.] 1 Phenoxyethanol INACTIVE INGREDIENT HIE492ZZ3T ALOCANE (LIDOCAINE HYDROCHLORIDE) OINTMENT [QUEST PRODUCTS, INC.] 1 Propanediol INACTIVE INGREDIENT 5965N8W85T ALOCANE (LIDOCAINE HYDROCHLORIDE) OINTMENT [QUEST PRODUCTS, INC.] 1 Water INACTIVE INGREDIENT 059QF0KO0R ALOCANE (LIDOCAINE HYDROCHLORIDE) OINTMENT [QUEST PRODUCTS, INC.] 1